GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Price-to-Funds-From-Operations

ProKidney (MEX:PROK) Price-to-Funds-From-Operations : (As of Jun. 22, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


ProKidney (MEX:PROK) Business Description

Industry
Traded in Other Exchanges
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.